spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

YHEC announces the promotions of Michelle Jenks and Rachael McCool to the role Project Director

YHEC

Michelle Jenks and Rachael McCool announced as YHEC Project Directors

YHEC is pleased to announce the promotions of Michelle Jenks from the Economic Modelling team and Rachael McCool from the Systematic Reviewing team to the role Project Director.

Michelle has a Masterís degree (MSc) in health economics from the University of York and has conducted economic evaluations and systematic reviews for both public and private sector clients. Michelle is the lead modeller in YHECís role as an External Assessment Centre for NICE and has also led on a range of economic evaluations conducted for clients within industry, such as cost-utility models and budget impact models. She often leads the development of early economic analyses to inform clinical trial design and pricing strategy.

Rachael has a BSc (Hons) in psychology from the University of York and has developed extensive experience in systematic reviewing and mixed treatment comparisons during her time at YHEC. Rachael has led systematic reviews requiring both quantitative and qualitative analyses and has worked on several reviews to support reimbursement submissions to NICE and other HTA bodies. She has also contributed to critiques of evidence submitted to NICEís medical technologies evaluation program. In her previous role, Rachael worked on developing and validating patient reported outcome measures using qualitative methods as well as critiquing existing measures against regulatory agency standards. She has worked with clients to assist them in their choice of PRO endpoint and outcome assessment in trials.
phone +44 (0)1904 323620
email andria.hanbury@york.ac.uk
web www.yhec.co.uk/
email Address: YHEC, Enterprise House, Innovation Way, University of York, York, YO10 5NQ, United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

New to the PPMA Show 2018: Bright Ideas - Ambassador Programme

A new initiative for PPMA Show visitors this year is the Bright Ideas - Ambassador Programme - a free advice service for start-up ventures and entrepreneurs.
More info >>


White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

Industry Events

Clinical Trial Supply East coast 2018

16-17 October 2018, King of Prussia, PA

This unique event brings together leading pharma, device and biotech professionals from across the East Coast region, to collaboratively enhance the clinical supply chain. Over the two days, delegates and speakers will discuss how to select forecasting and planning technology, how to reduce waste in clinical trials supplies, how to choose your packaging strategy, but we will also discover all the new technologies that will disrupt your clinical trials supplies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement